Skip to main content

TGen and Kronos to Study 570K SNPs in Alzheimer s Research

NEW YORK, Feb. 24 (GenomeWeb News) - The Translational Genomics Research Institute and Kronos Science Laboratories will cooperate in an Alzheimer's research study, the institute said yesterday.


The 18-month study is expected to cost approximately $6 million and will be jointly funded by TGen and Kronos, a subsidiary of Kronos Optimal Health. Both are located in Phoenix.


In the study, researchers will examine some 570,000 SNPs from deceased individuals who were confirmed to have Alzheimer's disease at autopsy, and another 1,000 dead who were confirmed to be free of the disease at autopsy. DNA samples will be obtained from brain banks in the USand Europe.


Kronos will have an exclusive worldwide license to all intellectual property that results from the research, and will look to develop a diagnostic for genetic predisposition.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.